Arovella Therapeutics Limited (ASX:ALA)
Australia
· Delayed Price · Currency is AUD 0.0730
-0.0040 (-5.19%)
Mar 9, 2026, 4:10 PM AEST
Arovella Therapeutics Revenue
Arovella Therapeutics had revenue of 3.21M AUD in the half year ending December 31, 2025, with 65.10% growth. This brings the company's revenue in the last twelve months to 3.21M, down -6.90% year-over-year. In the fiscal year ending June 30, 2025, Arovella Therapeutics had annual revenue of 3.44M with 76.22% growth.
Revenue (ttm)
3.21M
Revenue Growth
-6.90%
P/S Ratio
27.46
Revenue / Employee
118.88K
Employees
27
Market Cap
88.12M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 3.44M | 1.49M | 76.22% |
| Jun 30, 2024 | 1.95M | 497.46K | 34.20% |
| Jun 30, 2023 | 1.45M | 1.16M | 391.76% |
| Jun 30, 2022 | 295.81K | -693.91K | -70.11% |
| Jun 30, 2021 | 989.72K | -261.71K | -20.91% |
| Jun 30, 2020 | Pro | Pro | Pro |
| Jun 30, 2019 | Pro | Pro | Pro |
| Jun 30, 2018 | Pro | Pro | Pro |
| Jun 30, 2017 | Pro | Pro | Pro |
| Jun 30, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| LTR Pharma | 1.13M |
| Cynata Therapeutics | 1.69M |
| Paradigm Biopharmaceuticals | 8.45K |
| Alterity Therapeutics | 6.64M |
| Imugene | 3.94M |
| Radiopharm Theranostics | 16.28M |
| Island Pharmaceuticals | 62.85K |
| Botanix Pharmaceuticals | 21.92M |